Legal & General Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
47,353
+5,055
| +12% | +$117K | ﹤0.01% | 2208 |
|
|
2025
Q1 | $1.14M | Buy |
42,298
+7,758
| +22% | +$209K | ﹤0.01% | 2141 |
|
|
2024
Q4 | $1.85M | Buy |
34,540
+12,509
| +57% | +$670K | ﹤0.01% | 2004 |
|
|
2024
Q3 | $1M | Buy |
22,031
+746
| +4% | +$33.9K | ﹤0.01% | 2236 |
|
|
2024
Q2 | $892K | Buy |
21,285
+5,178
| +32% | +$217K | ﹤0.01% | 2236 |
|
|
2024
Q1 | $606K | Buy |
16,107
+6,226
| +63% | +$234K | ﹤0.01% | 2351 |
|
|
2023
Q4 | $106K | Hold |
9,881
| – | – | ﹤0.01% | 2760 |
|
|
2023
Q3 | $99.6K | Sell |
9,881
-313
| -3% | -$3.16K | ﹤0.01% | 2829 |
|
|
2023
Q2 | $121K | Buy |
10,194
+5,484
| +116% | +$65.1K | ﹤0.01% | 2816 |
|
|
2023
Q1 | $57K | Buy |
4,710
+2,968
| +170% | +$35.9K | ﹤0.01% | 2854 |
|
|
2022
Q4 | $22.8K | Hold |
1,742
| – | – | ﹤0.01% | 3124 |
|
|
2022
Q3 | $24K | Buy |
1,742
+302
| +21% | +$4.16K | ﹤0.01% | 3161 |
|
|
2022
Q2 | $18K | Sell |
1,440
-260
| -15% | -$3.25K | ﹤0.01% | 3272 |
|
|
2022
Q1 | $24K | Buy |
1,700
+461
| +37% | +$6.51K | ﹤0.01% | 3190 |
|
|
2021
Q4 | $24K | Hold |
1,239
| – | – | ﹤0.01% | 3212 |
|
|
2021
Q3 | $27K | Buy |
+1,239
| New | +$27K | ﹤0.01% | 3166 |
|